Monomethyl phthalate-d4

Monomethyl phthalate-d4 (2- (Methoxycarbonyl) benzoic acid-d4) is the deuterium labeled Monomethyl phthalate. Monomethyl phthalate is a phthalate metabolite. Monomethyl phthalate acts as a urinary biomarker of phthalates exposure and can be used as a standard for the determination of thyroid cancer and benign nodule[1].

Product Specifications

CAS Number

[1276197-40-0]

Product Name Alternative

2- (Methoxycarbonyl) benzoic acid-d4

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

99.04

Solubility

DMSO : 100 mg/mL (ultrasonic; warming)

Smiles

O=C(O)C1=C([2H])C([2H])=C([2H])C([2H])=C1C(OC)=O

Molecular Formula

C9H4D4O4

Molecular Weight

184.18

Precautions

H302, H315, H319, H335

References & Citations

[1]Chong Liu, et al. Urinary biomarkers of phthalates exposure and risks of thyroid cancer and benign nodule. J Hazard Mater. 2020 Feb 5;383:121189.|[2]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.